241 related articles for article (PubMed ID: 11478698)
1. Staging in untreated patients with small cell lung cancer.
Vrdoljak E; Mise K; Sapunar D; Rozga A; Marusic M
Neoplasma; 2001; 48(2):154-6. PubMed ID: 11478698
[TBL] [Abstract][Full Text] [Related]
2. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
3. The prognostic impact of tumor size in resected stage I non-small cell lung cancer: evidence for a two thresholds tumor diameters classification.
Christian C; Erica S; Morandi U
Lung Cancer; 2006 Nov; 54(2):185-91. PubMed ID: 16996167
[TBL] [Abstract][Full Text] [Related]
4. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
Milman N; Pedersen LM
Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer.
Patel S; Macdonald OK; Suntharalingam M
Cancer; 2009 Feb; 115(4):842-50. PubMed ID: 19117355
[TBL] [Abstract][Full Text] [Related]
6. Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come.
Brock MV; Hooker CM; Syphard JE; Westra W; Xu L; Alberg AJ; Mason D; Baylin SB; Herman JG; Yung RC; Brahmer J; Rudin CM; Ettinger DS; Yang SC
J Thorac Cardiovasc Surg; 2005 Jan; 129(1):64-72. PubMed ID: 15632826
[TBL] [Abstract][Full Text] [Related]
7. TNM stage is the most important determinant of survival in metachronous lung cancer.
Lee BE; Port JL; Stiles BM; Saunders J; Paul S; Lee PC; Altorki N
Ann Thorac Surg; 2009 Oct; 88(4):1100-5. PubMed ID: 19766788
[TBL] [Abstract][Full Text] [Related]
8. Non-small cell lung cancer with ipsilateral pulmonary metastases: prognosis analysis and staging assessment.
Lee JG; Lee CY; Kim DJ; Chung KY; Park IK
Eur J Cardiothorac Surg; 2008 Mar; 33(3):480-4. PubMed ID: 18249000
[TBL] [Abstract][Full Text] [Related]
9. Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients.
Pfannschmidt J; Muley T; Bülzebruck H; Hoffmann H; Dienemann H
Lung Cancer; 2007 Mar; 55(3):371-7. PubMed ID: 17123661
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).
Tsuchiya R; Suzuki K; Ichinose Y; Watanabe Y; Yasumitsu T; Ishizuka N; Kato H
J Thorac Cardiovasc Surg; 2005 May; 129(5):977-83. PubMed ID: 15867769
[TBL] [Abstract][Full Text] [Related]
11. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer.
Takeda S; Fukai S; Komatsu H; Nemoto E; Nakamura K; Murakami M;
Ann Thorac Surg; 2005 Apr; 79(4):1142-6. PubMed ID: 15797041
[TBL] [Abstract][Full Text] [Related]
12. [Pre-therapeutic prognostic factors of survival in small cell bronchial cancer. Retrospective study in a series of 112 patients].
Quoix E; Hedelin G; Seibert R; Popin E; Dietemann A; Roeslin N; Pauli G
Rev Mal Respir; 1993; 10(1):29-34. PubMed ID: 8383869
[TBL] [Abstract][Full Text] [Related]
13. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study.
Goya T; Asamura H; Yoshimura H; Kato H; Shimokata K; Tsuchiya R; Sohara Y; Miya T; Miyaoka E;
Lung Cancer; 2005 Nov; 50(2):227-34. PubMed ID: 16061304
[TBL] [Abstract][Full Text] [Related]
15. [Lung cancer: new staging system and prognosis].
Li C; Zhang R
Zhonghua Wai Ke Za Zhi; 2000 Mar; 38(3):189-91. PubMed ID: 11832024
[TBL] [Abstract][Full Text] [Related]
16. [Overall long-term survival in lung cancer analyzed in 610 unselected patients].
Sánchez de Cos Escuín J; Disdier Vicente C; Corral Peñafiel J; Riesco Miranda JA; Sojo González MA; Masa Jiménez JF
Arch Bronconeumol; 2004 Jun; 40(6):268-74. PubMed ID: 15161593
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
[TBL] [Abstract][Full Text] [Related]
18. High pretreatment serum concentration of basic fibroblast growth factor is a predictor of poor prognosis in small cell lung cancer.
Ruotsalainen T; Joensuu H; Mattson K; Salven P
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1492-5. PubMed ID: 12433733
[TBL] [Abstract][Full Text] [Related]
19. The surgical treatment of lung cancer: a retrospective analysis of 2004 cases.
Zhang D; Zhang R; Cheng G
Chin Med J (Engl); 1999 Jan; 112(1):25-8. PubMed ID: 11593634
[TBL] [Abstract][Full Text] [Related]
20. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
Steger V; Walles T; Kosan B; Walker T; Kyriss T; Veit S; Dippon J; Friedel G
Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]